|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
|
Fig. 3. Phenocopy of the ntn mutation by a cct3 antisense
morpholino oligonucleotide and phenotypic rescue of ntn mutant
embryos by the cct3 mRNA injection. Broken lines demarcate the tectum
(tec). (A) Dorsal view of wild-type (wt) and mutant (ntn) embryos at
4 dpf. An asterisk indicates the turbid tectum. White and black arrowheads
indicate small eyes with protruding lens and poor pectoral fins, respectively,
in the mutant embryo. An arrow indicates the reduced jaw. (B) Acridine Orange
staining of wild-type (wt) and mutant (ntn) embryos at 36 hpf. An
arrowhead indicates significant staining signals in the tectum of an
ntn mutant embryo. (C) Confocal optical section images of the tectum
of Bodipy-ceramide-stained wild-type (wt) and mutant (ntn) embryos at
46 hpf. An arrow indicates patches of dead cells. (D) Confocal composite
images of anti-acetylated tubulin immunostaining of wild-type (wt) and mutant
(ntn) embryos at 48 hpf. An arrowhead indicates absence of staining
signals in the tectum of the mutant embryo. (E) Confocal composite images of
the retinae of anti-acetylated tubulin immunostained wild-type (wt) and mutant
(ntn) embryos at 48 hpf. An arrow indicates decreased numbers of RGCs
and their axons in the mutant embryo at 48 hpf. (F) Dorsal view of
cct3 antisense and control morpholino oligonucleotide-injected
embryos at 4 dpf. White and black arrowheads indicate small eyes with
protruding lens and poor pectoral fins, respectively, in the antisense-treated
embryo. An asterisk indicates the turbid tectum. An arrow indicates the
reduced jaw. (G) Acridine Orange staining of cct3 antisense and
control morpholino oligonucleotide-injected embryos at 36 hpf. An arrowhead
indicates significant staining signals in the tectum of the antisense-treated
embryo. (H) Confocal optical section images of the tectum of
Bodipy-ceramide-stained cct3 antisense and control morpholino
oligonucleotide-injected embryos at 48 hpf. An arrow indicates patches of dead
cells. (I) Confocal composite images of anti-acetylated tubulin immunostaining
of cct3 antisense and control morpholino oligonucleotide-injected
embryos at 48 hpf. An arrowhead indicates the absence of staining signals in
the tectum of the antisense-treated embryo. (J) Confocal composite images of
the retinae of anti-acetylated tubulin immunostaining of cct3
antisense and control morpholino oligonucleotide-injected embryos at 48 hpf.
An arrow indicates decreased numbers of RGCs and their axons in the
antisense-treated embryo at 48 hpf. (K) Acridine Orange staining of
cct3 mRNA- and mock-injected ntn embryos at 36 hpf. An
arrowhead indicates the absence of staining signals in the tectum of the
treated ntn embryo. (L) Expression of nAChRß3 gene
promoter-driven EGFP in cct3 mRNA- and mock-injected ntn
embryos at 48 hpf. An arrowhead indicates the recovery of fluorescent signals
in RGCs of a cct3 mRNA-injected ntn embryo. (M) Genotyping
of a wild-type sibling (lane 1), cct3 mRNA- (lane 2) and
mock-injected (lane 3) ntn embryos using primers flanking the 143 bp
deletion in the cct3 gene. Lane M shows 100 bp DNA ladder as size
markers. Black and white arrowheads on the right indicate the 221 bp and 78 bp
PCR products representing the intact and deleted cct3 genes,
respectively. ac, anterior commissure neurons; dlf, dorsal longitudinal
fasciculus; p, pituitary gland; rgc, retinal ganglion cells; teg, tegmentum;
tg, trigeminal ganglion. Scale bars: 50 µm.
|
